TABLE 2.
Side effects reported during the first week after initiation of treatment
| Parameter | Valuea |
|
|---|---|---|
| AZI-CQ (n = 29) | AZI-SP (n = 29) | |
| Fever | 2 (7) | 1 (3) |
| Chills | 2 (7) | 0 (0) |
| Headache | 6 (21) | 4 (14) |
| Nausea | 4 (14) | 7 (24) |
| Vomiting | 2 (7) | 4 (14) |
| Diarrhea | 2 (7) | 2 (7) |
| Abdominal pain | 4 (14) | 3 (10) |
| Rash | 0 (0) | 0 (0) |
| Pruritus | 5 (17) | 0 (0) |
| Anorexia | 1 (3) | 2 (7) |
| Insomnia | 2 (7) | 0 (0) |
| Dizziness | 3 (10) | 1 (3) |
| Bone or joint pain | 1 (3) | 1 (3) |
| Otherb | 5 (17) | 1 (3) |
a
Data are numbers (%) of patients.
b
Cough (2), blocked ear (1), “heavy head” (1), and numbness of calf muscles (1) in the AZI-CQ group and cough (1) in the AZI-SP group.